Patience David bought TLSI
August 28, 2025 · Form 4 insider transaction
Patience David bought 248,899 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
248,899
Price
$0.00
Total value
N/A
InsiderPatience David
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 28, 2025
Filing dateAugust 29, 2025
Shares owned after538,899
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.; The stock options expire on December 31, 2027 if the revenue threshold is not met.